Hydralazine Dosing for Blood Pressure Control

Intravenous Dosing for Acute Hypertensive Emergencies

The European Society of Hypertension recommends hydralazine as a standard agent for severe hypertension in pregnancy, with treatment initiation within 60 minutes of onset, starting with 5 mg IV bolus, then 10 mg every 20-30 minutes to a maximum of 25 mg per episode, repeating in several hours as necessary 1, 2
For acute severe hypertension in pregnancy, the initial dose is 5 mg IV bolus, with subsequent doses of 10 mg IV every 20-30 minutes, and a maximum of 25 mg total per episode, with the option to repeat the cycle after several hours if needed 1, 3
The onset of action is 10 minutes, and the duration of effect is 1-4 hours 2
Labetalol is considered a second-line option, with a dose of 20 mg IV bolus, then 40-80 mg every 10 minutes to a maximum of 220 mg, due to potentially fewer adverse effects 1, 2

For heart failure, the initial dose is 37.5 mg three times daily, with a target dose of 75 mg three times daily for mortality benefit, according to the American Heart Association 4, 5
The evidence shows a 43% relative risk reduction in mortality with a number needed to treat (NNT) of 7 over 36 months 5

Blood pressure should be checked at 10-30 minutes, 1 hour, and 2-4 hours after each dose, with continuous monitoring required for IV administration to prevent overshoot hypotension 4
Reflex tachycardia requires concomitant beta-blocker therapy, and fluid retention requires concomitant diuretic therapy 4
The risk of lupus-like syndrome increases significantly at cumulative doses >200 mg/day 4
Common side effects include headache, palpitations, flushing, and vomiting, particularly in pregnancy 2, 3

IV hydralazine should not be used as first-line for non-obstetric hypertensive emergencies due to unpredictable response and prolonged duration of action, according to the European Society of Hypertension 5, 3
Three times daily dosing is only appropriate for heart failure with isosorbide dinitrate combination, while four times daily dosing is necessary for chronic hypertension management 4
Combination therapy with beta-blocker and diuretic is essential to counteract reflex tachycardia and fluid retention 4
In pregnancy, side effects may mimic worsening preeclampsia, and foetal distress secondary to abrupt maternal hypotension is a recognized risk 2

The American Heart Association recommends hydralazine combined with isosorbide dinitrate for self-identified African American patients with NYHA class III-IV heart failure with reduced ejection fraction who remain symptomatic despite optimal therapy with ACE inhibitors, beta-blockers, and aldosterone antagonists, with a Class I recommendation 6, 7
This combination demonstrates a remarkable mortality benefit, with a 43% relative risk reduction and a number needed to treat of only 7 over 36 months, and a 33% reduction in heart failure hospitalizations 6, 7
The American College of Cardiology suggests that hydralazine should not be used as monotherapy for chronic hypertension or as first-line therapy for most hypertensive emergencies, but can be considered for severe hypertension in pregnancy or as a last-resort agent for resistant hypertension when combined with beta-blockers and diuretics 8, 6

The American Heart Association recommends considering hydralazine-isosorbide dinitrate combination for patients with current or prior symptomatic HFrEF who cannot tolerate ACE inhibitors or ARBs due to drug intolerance, hypotension, or renal insufficiency, with a Class IIa recommendation 6, 7
The combination should not substitute for ACE inhibitor/ARB therapy in patients tolerating these medications without difficulty 6, 7

The American College of Cardiology suggests that hydralazine should not be used as first-line therapy for most hypertensive emergencies due to unpredictable blood pressure response and prolonged duration of action, but can be administered 10 mg via slow IV infusion, repeating every 4-6 hours as needed 8
Preferred alternatives include nicardipine or clevidipine for more predictable titration 8

The American College of Cardiology recommends avoiding hydralazine in patients with advanced aortic stenosis due to unpredictable blood pressure effects 8
Hydralazine should be avoided in patients with reactive airways disease when considering combination with beta-blockers 8

Common adverse effects of hydralazine include headache, dizziness, palpitations, flushing, and gastrointestinal complaints, with adherence generally poor due to high pill burden and adverse reactions 6, 7